RxDoctor Payments Data

Frank Canavan

Physician Assistant · Upland, CANPI 1194811984

Payments from drug & device makers

$8,989in general payments, 2019–2025

Across 406 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Sanofi$1K
  • GSK$939
  • CSL Behring$767
  • AbbVie$759
  • LEO Pharma Inc.$704
  • plus $3K from 22 others

What the payments were for

  • Food & beverage$8,90599%
  • Education$841%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,989 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$29,966
Breo ElliptaFluticasone/Vilanterol21$11,062
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$10,335
Azelastine Hcl90$3,545
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$1,444
Fluticasone Propionate50$909
Albuterol Sulfate HfaAlbuterol Sulfate35$837
Triamcinolone Acetonide34$716
Montelukast Sodium40$542
Ipratropium Bromide18$307
Levocetirizine Dihydrochloride17$150
Prednisone15$49

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$939$41,02858 claims
AstraZenecaBreztri Aerosphere$1,439$10,33512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Upland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →